Brief: Nurix Therapeutics - Maintains Operating Account At Svb With Cash Balance Of Less Than 1% Of Co's Total Cash, Cash Equivalents And Marketable Securities
March 13 (Reuters) - Nurix Therapeutics Inc NRIX.O :
* NURIX THERAPEUTICS - MAINTAINS OPERATING ACCOUNT AT SVB
WITH
CASH BALANCE OF LESS THAN 1% OF CO'S TOTAL CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES
* NURIX THERAPEUTICS SAYS CO'S DIRECT EXPOSURE TO SVB,
EXPOSURE TO
LOSS AS RESULT OF SVB’S RECEIVERSHIP IS IMMATERIAL
* NURIX THERAPEUTICS SAYS BELIEVES THAT ITS FUNDS CURRENTLY
HELD
AT SVB WILL BE FULLY AVAILABLE IF AND WHEN NEEDED
Source text: [ID:https://tinyurl.com/49nkw9w7https://tinyurl.com/49nkw9w7
]
Further company coverage: NRIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nurix Therapeutics
See all newsNurix Therapeutics Q3 swings to profit on Roche collaboration
Brief: Nurix Extends Gilead Collaboration For Oncology Program
Commercialize Potential Best-In-Class Btk Degrader Bexobrutideg Across Malignant Hematology, Immunology And Neurology
Nurix Therapeutics Q2 revenue falls sharply, net loss widens; strikes up to $2.3 bln collab with Roche
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis